Lutherville, MD, United States of America

Francis P Kuhajda

This inventor holds 11 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents. Top assignees: Johns Hopkins University, Fasgen, Inc.. Active years: 1997-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis P Kuhajda. Retrieved from https://idiyas.com/inventor/francis-p-kuhajda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 7)

% Patents Active = 72.7

CIPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 194(Granted Patents)

Location History:

Lutherville, MD (US) (1997 - 2008)
Baltimore, MD (US) (2010)

Company Filing History:

11 out of 3,801

Johns Hopkins University

where one patent can have more than one assignee

Years Active: 1997-2010

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7649012 - Compounds, pharmaceutical compositions containing same, and methods of use for same (2010-01-19),

2. 7459481 - Stimulation of CPT-1 as a means to reduce weight (2008-12-02),

3. 7385086 - Antimicrobial compounds (2008-06-10),

4. 6713654 - Antimicrobial compounds (2004-03-30),

5. 5981575 - Inhibition of fatty acid synthase as a means to reduce adipocyte mass (1999-11-09),

6. 5872217 - Antibodies which specifically bind a cancer related antigen (1999-02-16),

7. 5864011 - Cancer related antigen (1999-01-26),

8. 5759837 - Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway (1998-06-02),

9. 5759791 - Cancer related antigen (1998-06-02),

10. 5665874 - Cancer related antigen (1997-09-09),

11. 5614551 - Inhibitors of fatty acid synthesis as antimicrobial agents (1997-03-25),

Title: The Innovative Contributions of Francis P. Kuhajda

Introduction

Francis P. Kuhajda is a notable inventor based in Lutherville, MD (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Kuhajda has focused on developing innovative compounds and methods that address critical health issues, including cancer treatment and weight management.

Latest Patents

Kuhajda's latest patents include a pharmaceutical composition that comprises a diluent and a specific compound designed for various therapeutic applications. These formulations are aimed at treating cancer, promoting weight loss, and addressing microbially-based infections. His work emphasizes the stimulation of carnitine palmitoyl transferase-1 (CPT-1) as a means to enhance fatty acid oxidation and reduce adiposity without inhibiting fatty acid synthesis. This innovative approach has the potential to improve energy production while preserving lean mass in patients.

Career Highlights

Throughout his career, Kuhajda has been associated with prestigious institutions such as The Johns Hopkins University and Fasgen, Inc. His research has led to advancements in pharmaceutical compositions that are not only effective but also tailored to meet the needs of patients requiring weight management and cancer treatment.

Collaborations

Kuhajda has collaborated with esteemed colleagues, including Gary R. Pasternack and James D. Dick, contributing to a rich exchange of ideas and innovations in the pharmaceutical field.

Conclusion

Francis P. Kuhajda's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and research continue to pave the way for new therapeutic options that can significantly impact patient care and health outcomes.

Profile summary based on public USPTO records.